Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer ...
Baron International Growth Fund retreated 2.96% in Q4 2025 despite a full-year gain of 21.16%. Read the full analysis for more details.
VectorCertain's AIEOG Conformance Suite — the first commercial platform mapped against the U.S. Treasury's FS AI RMF — ...
Vector and Nammo Defense Systems partner to produce NDAA-compliant, kinetically-integrated UAS platforms for small-drone battlefield deployment.
Baron International Growth Fund reports its Q4 2025 performance, highlighting impacts from AI disruption and sector-specific shifts. Read the full analysis for more details.
Metilience unveils a hybrid AI reasoning engine for high-stakes exams, leveraging structured cognitive error analysis ...
Merck Animal Health shared earlier this week that the FDA approved its atinvicitinib tablets (NUMELVI; Merck Animal Health), a once daily, first line treatment for canine patients 6 months and older ...
FORT BELVOIR, Va. – On Feb. 25, the Hon. Brent Ingraham, Assistant Secretary of the Army for Acquisition, Logistics and Technology, joined leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results